Tuesday, the agency signed off on SpringWorks’ Gomekli (mirdametinib) as a treatment for the rare genetic disorder ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

Had the Giants decided to match Barkley’s free-agent contract offer from the Eagles last March, he would’ve re-signed to ...

The big-game script for the Chiefs includes Patrick Mahomes scrambling for first downs, Andy Reid getting creative with his ...

With retirement speculation swirling, Kelce didn’t catch a pass in the first half for the first time in his 25-game playoff ...

In a game between two of the best fourth-down offenses in the NFL, the Eagles went for a fourth-and-2 on the first drive of ...

Brandon Graham is living the John Elway and Michael Strahan fantasy. Barring a change of heart, Graham played the final game ...

Heroes, zeros from the Eagles ’ 40-22 win over the Chiefs in Super Bowl 2025 on Sunday: Jalen Hurts was a worthy MVP, ...

The Chiefs were dominated with two $80 million players on the bookends — converted left tackle Joe Thuney and right tackle ...

With the settlement, Teva will not market the Auvelity generic until September 30, 2038, Axsome said in a Monday press ...

Recently hired Jets head coach Aaron Glenn trained Eagles safety C.J. Gardner-Johnson in high school, was the defensive backs ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...